FGF19 and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: FGF19 transgenic mice remain lean on an obesogenic diet and have an increased metabolic rate [49], neither of which is desirable in SBS patients who struggle to maintain or gain weight.